SLC22A3 and coronary artery disorder: In addition, SLC22A3 rs1810126 was significantly associated with decreased CAD risk in an additive model (OR = 0.78; 95% CI = 0.62–0.99; p = 0.041) and recessive model (OR = 0.59; 95%CI = 0.39-0.89; p = 0.012).